• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从苦瓜中生物活性化合物的抗糖尿病和抗炎活性的体外和计算阐明

In vitro and in silico elucidation of antidiabetic and anti-inflammatory activities of bioactive compounds from Momordica charantia L.

机构信息

Vegetable and Fruit Improvement Center, Department of Horticultural Sciences, Texas A&M University, 1500 Research Parkway, Suite A120, College Station, TX 77845, USA.

Department of Poultry Science, Texas A&M University, College Station, TX 77845, USA.

出版信息

Bioorg Med Chem. 2019 Jul 15;27(14):3097-3109. doi: 10.1016/j.bmc.2019.05.035. Epub 2019 May 23.

DOI:10.1016/j.bmc.2019.05.035
PMID:31196754
Abstract

Bitter melon (Momordica charantia) has been used to manage diabetes and related conditions in various parts of the world. In the present study, ten compounds were isolated from acetone and methanol extracts of bitter melon. The chemical structures of compounds were unambiguously elucidated by 1D, 2D NMR, and high-resolution mass spectra. Identified compounds 1-7 exhibited significant inhibition of α-amylase and moderate inhibition of α-glucosidase activities. Momordicoside G and gentisic acid 5-O-β-d-xyloside showed the highest inhibition of α-amylase (70.5%), and α-glucosidase (56.4%), respectively. Furthermore, molecular docking studies of isolated compounds 1-7 were able to bind to the active sites of both enzymes. Additionally, the isolated compounds 1-7 significantly attenuated lipopolysaccharide (LPS)-induced inflammation, downregulating the expression of pro-inflammatory markers NF-κB, INOS, IL-6, IL-1β, TNF-α, and Cox-2 in murine macrophage RAW 264.7 cells. One phenolic derivative, gentisic acid 5-O-β-d-xyloside, was isolated and identified for the first time from bitter melon, and significantly suppressed the expression of Cox-2 and IL-6 compared to the LPS-treated group. α-Amylase and α-glucosidase are targets of anti-diabetes drugs, our findings suggest that compounds purified from bitter melon may have potential to use as functional food ingredients for the prevention of type 2 diabetes and related inflammatory conditions.

摘要

苦瓜(Momordica charantia)已被用于世界各地管理糖尿病和相关病症。在本研究中,从苦瓜的丙酮和甲醇提取物中分离出了 10 种化合物。通过 1D、2D NMR 和高分辨率质谱明确了化合物的化学结构。鉴定出的化合物 1-7 对α-淀粉酶具有显著的抑制作用,对α-葡萄糖苷酶也具有中等抑制作用。苦瓜苷 G 和龙胆酸 5-O-β-D-吡喃木糖苷对α-淀粉酶(70.5%)和α-葡萄糖苷酶(56.4%)的抑制作用最强。此外,对分离出的化合物 1-7 的分子对接研究表明,它们能够与两种酶的活性部位结合。此外,分离出的化合物 1-7 可显著减轻脂多糖(LPS)诱导的炎症,下调鼠巨噬细胞 RAW 264.7 细胞中促炎标志物 NF-κB、INOS、IL-6、IL-1β、TNF-α和 Cox-2 的表达。一种酚类衍生物,龙胆酸 5-O-β-D-吡喃木糖苷,首次从苦瓜中分离鉴定,与 LPS 处理组相比,它对 Cox-2 和 IL-6 的表达有显著的抑制作用。α-淀粉酶和α-葡萄糖苷酶是抗糖尿病药物的靶点,我们的研究结果表明,从苦瓜中纯化的化合物可能有潜力作为功能性食品成分,用于预防 2 型糖尿病和相关炎症。

相似文献

1
In vitro and in silico elucidation of antidiabetic and anti-inflammatory activities of bioactive compounds from Momordica charantia L.从苦瓜中生物活性化合物的抗糖尿病和抗炎活性的体外和计算阐明
Bioorg Med Chem. 2019 Jul 15;27(14):3097-3109. doi: 10.1016/j.bmc.2019.05.035. Epub 2019 May 23.
2
Cucurbitane-type compounds from Momordica charantia: Isolation, in vitro antidiabetic, anti-inflammatory activities and in silico modeling approaches.苦瓜中的葫芦烷型化合物:分离、体外抗糖尿病、抗炎活性及计算机模拟方法。
Bioorg Chem. 2019 Jun;87:31-42. doi: 10.1016/j.bioorg.2019.02.040. Epub 2019 Feb 26.
3
Anti-Inflammatory, Antidiabetic Properties and In Silico Modeling of Cucurbitane-Type Triterpene Glycosides from Fruits of an Indian Cultivar of L.印度品种苦瓜果实中的葫芦烷型三萜糖苷的抗炎、抗糖尿病特性及计算机模拟
Molecules. 2021 Feb 16;26(4):1038. doi: 10.3390/molecules26041038.
4
Investigation of Biological Activities of Wild Bitter Melon ( Linn. Var. Abbreviata Ser.).野生苦瓜(Linn. Var. Abbreviata Ser.)生物活性的研究。
Biomolecules. 2019 May 30;9(6):211. doi: 10.3390/biom9060211.
5
BG-4, a novel bioactive peptide from momordica charantia, inhibits lipopolysaccharide-induced inflammation in THP-1 human macrophages.从苦瓜中提取的新型生物活性肽 BG-4 可抑制脂多糖诱导的 THP-1 人巨噬细胞炎症反应。
Phytomedicine. 2018 Mar 15;42:226-232. doi: 10.1016/j.phymed.2018.03.047. Epub 2018 Mar 19.
6
Thermal treatment enhances the α-glucosidase inhibitory activity of bitter melon (Momordica charantia) by increasing the free form of phenolic compounds and the contents of Maillard reaction products.热处理通过增加游离酚类化合物的形式和 Maillard 反应产物的含量来提高苦瓜(Momordica charantia)的α-葡萄糖苷酶抑制活性。
J Food Sci. 2021 Jul;86(7):3109-3121. doi: 10.1111/1750-3841.15798. Epub 2021 Jun 19.
7
Synergistic antidiabetic activity of Taraxacum officinale (L.) Weber ex F.H.Wigg and Momordica charantia L. polyherbal combination.蒲公英(Taraxacum officinale (L.) Weber ex F.H.Wigg)和苦瓜(Momordica charantia L.)复方草药组合的协同抗糖尿病活性。
Biomed Pharmacother. 2022 Jan;145:112401. doi: 10.1016/j.biopha.2021.112401. Epub 2021 Nov 13.
8
Inhibitory Effects of Cucurbitane-Type Triterpenoids from Fruit on Lipopolysaccharide-Stimulated Pro-Inflammatory Cytokine Production in Bone Marrow-Derived Dendritic Cells.苦瓜烷型三萜类化合物对脂多糖刺激骨髓来源树突状细胞产生促炎细胞因子的抑制作用。
Molecules. 2021 Jul 23;26(15):4444. doi: 10.3390/molecules26154444.
9
EMCD, a hypoglycemic triterpene isolated from Momordica charantia wild variant, attenuates TNF-α-induced inflammation in FL83B cells in an AMP-activated protein kinase-independent manner.从苦瓜野生变种中分离得到的降糖三萜 EMCD 通过不依赖 AMP 激活蛋白激酶的方式减轻 TNF-α 诱导的 FL83B 细胞炎症。
Eur J Pharmacol. 2012 Aug 15;689(1-3):241-8. doi: 10.1016/j.ejphar.2012.05.033. Epub 2012 Jun 7.
10
In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.).两种苦瓜(苦瓜属)蛋白质提取物的体外和体内α-淀粉酶及α-葡萄糖苷酶抑制活性
BMC Complement Altern Med. 2016 Jul 18;16 Suppl 1(Suppl 1):185. doi: 10.1186/s12906-016-1085-1.

引用本文的文献

1
Multidimensional Uses of Bitter Melon ( L.) Considering the Important Functions of its Chemical Components.基于苦瓜化学成分的重要功能探讨苦瓜的多维用途。
Curr Org Synth. 2025;22(4):516-530. doi: 10.2174/0115701794285586240523101245.
2
Comprehensive Studies on the Regulation of Type 2 Diabetes by Cucurbitane-Type Triterpenoids in L.: Insights from Network Pharmacology and Molecular Docking and Dynamics.葫芦烷型三萜类化合物对枸杞中2型糖尿病调控的综合研究:来自网络药理学、分子对接和动力学的见解
Pharmaceuticals (Basel). 2025 Mar 27;18(4):474. doi: 10.3390/ph18040474.
3
The recent advance and prospect of natural source compounds for the treatment of heart failure.
用于治疗心力衰竭的天然来源化合物的最新进展与展望
Heliyon. 2024 Feb 25;10(5):e27110. doi: 10.1016/j.heliyon.2024.e27110. eCollection 2024 Mar 15.
4
Synergistic effects of , , and on metabolic syndrome targets: enzyme inhibition and in silico analyses.[具体物质名称1]、[具体物质名称2]和[具体物质名称3]对代谢综合征指标的协同作用:酶抑制作用及计算机模拟分析
Heliyon. 2024 Jan 18;10(2):e24907. doi: 10.1016/j.heliyon.2024.e24907. eCollection 2024 Jan 30.
5
L.-Diabetes-Related Bioactivities, Quality Control, and Safety Considerations.L. - 糖尿病相关生物活性、质量控制及安全性考量
Front Pharmacol. 2022 May 17;13:904643. doi: 10.3389/fphar.2022.904643. eCollection 2022.
6
Molecular Docking and Simulation Studies of Antidiabetic Agents Devised from Hypoglycemic Polypeptide-P of .基于低血糖肽-P 的抗糖尿病药物的分子对接和模拟研究。
Biomed Res Int. 2021 Sep 17;2021:5561129. doi: 10.1155/2021/5561129. eCollection 2021.
7
Insight into Gentisic Acid Antidiabetic Potential Using In Vitro and In Silico Approaches.利用体外和计算机模拟方法洞察龙胆酸的抗糖尿病潜力。
Molecules. 2021 Mar 30;26(7):1932. doi: 10.3390/molecules26071932.
8
Anti-Inflammatory, Antidiabetic Properties and In Silico Modeling of Cucurbitane-Type Triterpene Glycosides from Fruits of an Indian Cultivar of L.印度品种苦瓜果实中的葫芦烷型三萜糖苷的抗炎、抗糖尿病特性及计算机模拟
Molecules. 2021 Feb 16;26(4):1038. doi: 10.3390/molecules26041038.
9
The Effect of in the Treatment of Diabetes Mellitus: A Review.(此处原文不完整,缺少关键信息,无法准确完整翻译,仅按现有内容翻译为)《(某物质或方法等)在糖尿病治疗中的作用:综述》
Evid Based Complement Alternat Med. 2021 Jan 16;2021:3796265. doi: 10.1155/2021/3796265. eCollection 2021.
10
A Review of Malaysian Herbal Plants and Their Active Constituents with Potential Therapeutic Applications in Sepsis.马来西亚草药植物及其活性成分在脓毒症中潜在治疗应用的综述
Evid Based Complement Alternat Med. 2020 Oct 28;2020:8257817. doi: 10.1155/2020/8257817. eCollection 2020.